Health
UK is getting Pfizer’s COVID-19 vaccine next week, but India will have to wait till April for Covishield – Moneycontrol
Serum Institute’s COVID-19 vaccine supply to private companies and in the open market will start only after orders from the government are met.
COVID-19 vaccine (representative image)
Serum Institute of India (SII) is likely to start selling its COVID-19 vaccine in the open market after March-April 2021 as there is a substantial demand from companies which want to buy doses in bulk for their employees, The Economic Times reported.
In an email response to the newspaper, SII CEO Adar Poonawalla confirmed that private market availability will probably be post March-April 2021, if the vaccine is found to be immunogenic and safe.
While initial…
-
Business22 hours agoIs Warren Buffett’s Berkshire Hathaway the smartest investment you can make today?
-
General22 hours agoTop chess player Magnus Carlsen forced into draw in historic game against over 134,000 people
-
Noosa News8 hours agoCommissioner thanks police officer who threw a speed radar at a car
-
General22 hours agoTaiwan’s President Lai Ching-te calls for peace and dialogue with China while also calling for defence boosts